Abstract:DddA-derived cytosine base editors (DdCBEs) enable the targeted introduction of C·G-to-T·A conversions in mitochondrial DNA (mtDNA). DdCBEs are often deployed as pairs, with each arm comprised of a transcription activator-like effector (TALE), a split double-stranded DNA deaminase half, and a uracil glycosylase inhibitor. This pioneering technology has helped improve our understanding of cellular processes involving mtDNA and has paved the way for the development of models and therapies for genetic disorders caused by pathogenic mtDNA variants. Nonetheless, given the intrinsic properties of TALE proteins, several target sites in human mtDNA remain out of reach to DdCBEs and other TALE-based technologies. Specifically, due to the conventional requirement for a thymine immediately upstream of the TALE target sequences (i.e., the 5′-T constraint), over 150 loci in the human mitochondrial genome are presumed to be inaccessible to DdCBEs. Previous attempts at circumventing this constraint, either by developing monomeric DdCBEs or utilizing DNA-binding domains alternative to TALEs, have resulted in suboptimal specificity profiles with reduced therapeutic potential. Here, aiming to challenge and elucidate the relevance of the 5′-T constraint in the context of DdCBE-mediated mtDNA editing, and to expand the range of motifs that are editable by this technology, we generated αDdCBEs that contain modified TALE proteins engineered to recognize all 5′ bases. Notably, 5′-T-noncompliant, canonical DdCBEs efficiently edited mtDNA at diverse loci. However, DdCBEs were frequently outperformed by αDdCBEs, which consistently displayed significant improvements in activity and specificity, regardless of the 5′-most bases of their TALE binding sites. Furthermore, we showed that αDdCBEs are compatible with DddAtox and its derivatives DddA6, and DddA11, and we validated TALE shifting with αDdCBEs as an effective approach to optimize base editing outcomes at a single target site. Overall, αDdCBEs enable efficient, specific, and unconstrained mitochondrial base editing.

High-efficiency plastome base editing in rice with TAL cytosine deaminase

Targeted C•G-to-T•A base editing with TALE-cytosine deaminases in plants

Base editing of organellar DNA with programmable deaminases

A DddA ortholog-based and transactivator-assisted nuclear and mitochondrial cytosine base editors with expanded target compatibility

Improved plant cytosine base editors with high editing activity, purity, and specificity

Targeted A-to-G base editing of chloroplast DNA in plants

Exploring C-to-G and A-to-Y Base Editing in Rice by Using New Vector Tools

Engineering RsDddA as mitochondrial base editor with wide target compatibility and enhanced activity

Chloroplast and mitochondrial DNA editing in plants

Expanding the Editing Window of Cytidine Base Editors With the Rad51 DNA-Binding Domain in Rice

Strand-preferred base editing of organellar and nuclear genomes using CyDENT

Diverse nucleotide substitutions in rice base editing mediated by novel TadA variants

Precision mitochondrial DNA editing with high-fidelity DddA-derived base editors

Unconstrained Precision Mitochondrial Genome Editing with αDdCBEs

Efficient DNA base editing via an optimized DYW-like deaminase

A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing

Compact zinc finger architecture utilizing toxin-derived cytidine deaminases for highly efficient base editing in human cells

Expanded base editing in rice and wheat using a Cas9-adenosine deaminase fusion

Fusion of a rice endogenous N-methylpurine DNA glycosylase to a plant adenine base transition editor ABE8e enables A-to-K base editing in rice plants

Strand-selective base editing of human mitochondrial DNA using mitoBEs

High performance TadA-8e derived cytosine and dual base editors with undetectable off-target effects in plants